3 false false false false false false false false false false true false false false false false false No description of principal activity 2023-04-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 13275984 2023-04-01 2024-03-31 13275984 2024-03-31 13275984 2023-03-31 13275984 2022-04-01 2023-03-31 13275984 2023-03-31 13275984 2022-03-31 13275984 core:MotorVehicles 2023-04-01 2024-03-31 13275984 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 13275984 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 13275984 bus:Director1 2023-04-01 2024-03-31 13275984 bus:Director2 2023-04-01 2024-03-31 13275984 core:WithinOneYear 2024-03-31 13275984 core:WithinOneYear 2023-03-31 13275984 core:MotorVehicles 2023-03-31 13275984 core:MotorVehicles 2024-03-31 13275984 core:ShareCapital 2024-03-31 13275984 core:ShareCapital 2023-03-31 13275984 core:RetainedEarningsAccumulatedLosses 2024-03-31 13275984 core:RetainedEarningsAccumulatedLosses 2023-03-31 13275984 core:MotorVehicles 2023-03-31 13275984 bus:SmallEntities 2023-04-01 2024-03-31 13275984 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 13275984 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 13275984 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 13275984 bus:FullAccounts 2023-04-01 2024-03-31 13275984 bus:OrdinaryShareClass1 2024-03-31 13275984 bus:OrdinaryShareClass1 2023-03-31 13275984 bus:OrdinaryShareClass2 2024-03-31 13275984 bus:OrdinaryShareClass2 2023-03-31 13275984 bus:AllOrdinaryShares 2024-03-31 13275984 bus:AllOrdinaryShares 2023-03-31 13275984 core:OfficeEquipment 2023-04-01 2024-03-31 13275984 core:OfficeEquipment 2024-03-31 13275984 core:OtherRelatedParties 2023-04-01 2024-03-31
COMPANY REGISTRATION NUMBER: 13275984
DAS Anaesthetics UK Limited
Filleted Unaudited Financial Statements
31 March 2024
DAS Anaesthetics UK Limited
Financial Statements
Year ended 31 March 2024
Contents
Page
Statement of financial position
1
Notes to the financial statements
3
DAS Anaesthetics UK Limited
Statement of Financial Position
31 March 2024
2024
2023
Note
£
£
£
£
Fixed assets
Tangible assets
5
18,354
23,274
Current assets
Debtors
6
20,100
33,157
Cash at bank and in hand
200,704
92,058
---------
---------
220,804
125,215
Creditors: amounts falling due within one year
7
42,663
32,316
---------
---------
Net current assets
178,141
92,899
---------
---------
Total assets less current liabilities
196,495
116,173
Provisions
Taxation including deferred tax
4,364
5,818
---------
---------
Net assets
192,131
110,355
---------
---------
Capital and reserves
Called up share capital
8
100
100
Profit and loss account
192,031
110,255
---------
---------
Shareholders funds
192,131
110,355
---------
---------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
DAS Anaesthetics UK Limited
Statement of Financial Position (continued)
31 March 2024
These financial statements were approved by the board of directors and authorised for issue on 27 March 2025 , and are signed on behalf of the board by:
Dr D A Das
Dr A C Vijay
Director
Director
Company registration number: 13275984
DAS Anaesthetics UK Limited
Notes to the Financial Statements
Year ended 31 March 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 146 New London Road, Chelmsford, Essex, CM2 0AW, England.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for services rendered, stated net of discounts.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Motor vehicles
-
25% reducing balance
Office equipment
-
20% straight line
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 3 (2023: 3 ).
5. Tangible assets
Motor vehicles
Office equipment
Total
£
£
£
Cost
At 1 April 2023
38,193
38,193
Additions
999
999
--------
----
--------
At 31 March 2024
38,193
999
39,192
--------
----
--------
Depreciation
At 1 April 2023
14,919
14,919
Charge for the year
5,819
100
5,919
--------
----
--------
At 31 March 2024
20,738
100
20,838
--------
----
--------
Carrying amount
At 31 March 2024
17,455
899
18,354
--------
----
--------
At 31 March 2023
23,274
23,274
--------
----
--------
6. Debtors
2024
2023
£
£
Amounts owed by undertakings in which the company has a participating interest
20,100
33,157
--------
--------
7. Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
289
1,200
Accruals and deferred income
1,494
1,290
Corporation tax
27,073
16,079
Director loan accounts
13,807
13,747
--------
--------
42,663
32,316
--------
--------
8. Called up share capital
Issued, called up and fully paid
2024
2023
No.
£
No.
£
A Ordinary shares of £ 1 each
50
50
50
50
B Ordinary shares of £ 1 each
50
50
50
50
----
----
----
----
100
100
100
100
----
----
----
----
9. Related party transactions
At the balance sheet date the company owed its directors £13,807 (2023: £13,747) in the form of a loan account. This loan, which is shown amongst creditors, is interest free and repayable on demand. The company is a member in Phoenix Anaesthetic Group LLP. Included in debtors is £20,100 (2023: £33,157) due from Phoenix Anaesthetic Group LLP, taking into account the company's share of profits for the year of £76,386 (2023: £89,219).